Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour
The starting 0.25mg dose is 10 units
Many patients notice improvements in energy and recovery within the first few weeks, but the cellular marker improvement is dependent on baseline oxidative stress
On the other hand, in case of excessive distress, cells are exposed to high levels of ROS which can cause neuroinflammation, damage to the blood-brain barrier (BBB) and impairment to astrocyte crosstalk leading to ASD (Russo et al., 2018)
Symptoms of G6PD deficiency are triggered by exposure to certain foods, medications, infection and/or environmental factors 2,4
& Paul, A
